title: Insulin in sepsis and septic shock.
abstract: NF-kappaB activation, and elevated concentrations of macrophage migration inhibitory factor (MIF), tumor necrosis factor-alpha (TNF-alpha), interleukin-1(IL-1), IL-6, free radicals, inducible nitric oxide (iNO), and stress hyperglycemia occurs in sepsis and this leads to systemic inflammatory response and myocardial depression seen in sepsis and septic shock. Conversely, insulin suppresses production of MIF, TNF-alpha, IL-1, IL-6, and free radicals, enhances endothelial NO generation, and enhances the production of anti-inflammatory cytokines IL-4, and IL-10, corrects stress hyperglycemia and improves myocardial function. This supports my earlier proposal that insulin (with or without glucose and potassium) therapy to maintain euglycemia suppresses the inflammatory response, improves myocardial function, and thus, is of benefit in acute myocardial infarction, sepsis andseptic shock.
authors: Department of Nutrition and Surgery, SUNY Upstate Medical University Syracause, NY, USA.
authors: Undurti N
authors: UN
authors: Das
mesh_terms: D000818:Animals; D009202:Cardiomyopathies / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000502:physiology / Q000627:therapeutic use*; D007333:Insulin Resistance; D018805:Sepsis / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D012772:Shock, Septic / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin